The influence of a sympathetiocolytic drug on the development of experimental atherosclerosis.
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D002784:Cholesterol / Q000378:metabolism*; D004036:Diet, Atherogenic; D008297:Male; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology*
D013565:Sympatholytics; D002784:Cholesterol